Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction
Early a small decline in left ventricular ejection fraction can predict trastuzumab-related cardiotoxicity in patients with breast cancer: A study using 13 years of registry data
Predictive value of echocardiographic measurement for evaluating diastolic dysfunction in chronic atrial fibrillation patients with preserved left ventricular ejection fraction